1. Home
  2. Medical Devices
  3. global-insulin-pen-market-56100
post image

Global Insulin Pen Market Analysis and Forecast 2019-2028

  • Report ID: 56100
  • Date: Dec, 2022
  • Pages: 120
  • Category: Medical Devices

Global Insulin Pen Market Analysis and Forecast 2019-2028

The global insulin pen market is expected to witness a considerable growth rate of around 7.3% during the forecast period 2022–2028. People diagnosed with type 1 diabetes have to inject insulin on the regular basis. The increasing patient pool of type 1 diabetes is a major factor driving the demand for insulin pens globally.

In addition, continuous technological advancements, like the use of smartphones and the internet with insulin pen offerings are expected to spur the growth of insulin pens in the forthcoming years. The needles on a reusable pen should be replaced periodically. Reusable pens are expected to gain significant traction, mainly driven by a growing base of environment and cost-conscious consumers.

Market Segmentation

The global insulin pen market is segmented into type, product type, diabetes type, distribution channel, end-user, and region. Based on Type, the market is divided into Conventional Insulin Pen and Smart Insulin Pen. On the basis of Product Type, the market is divided into Reusable Pen and Disposable Pen. Based on diabetes type, the market is divided into Diabetes Type 1 and Diabetes Type 2.

On the basis of the Distribution Channel, the market is segmented into Hospital Pharmacies, Conventional Retail Pharmacies, and Online Pharmacies. Based on End Users, the market is divided into Hospitals, Clinics, and Homecare Settings.

Based on region, the market is divided into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and Middle East & Africa. Further, North America is divided into US and Canada. Latin America is further segmented on the basis of Brazil, Mexico, and the Rest of Latin America. Western Europe is further segmented into Germany, the UK, France, Spain, Italy, Benelux, Nordic, and the rest of western Europe. Eastern Europe is segmented into Russia, Poland, and the rest of Eastern Europe.

Based on the Asia Pacific, the market is further segmented into China, India, Japan, South Korea, Australia, ASEAN (Indonesia, Vietnam, Malaysia, etc.) countries, and the rest of Asia Pacific. Lastly, on the basis of the Middle East & Africa market is segmented into GCC Countries, South Africa, Turkey, and the rest of the Middle East & Africa.

Market structure and competitive landscape

The global insulin pen market is fragmented in nature, some of the prominent players that contribute significantly to the market growth include Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, Medtronic plc, B. Braun Holding GmbH & Co. KG, Owen Mumford Ltd., YpsoMed AG, Biocon Limited, Terumo Medical Corporation, among others.

Product Launches, Mergers & Acquisitions, joint ventures, and R&D activities are key strategies adopted by the players in the global insulin pen market. These companies adopt numerous approaches to strengthen their market share and gain a competitive edge over other competitors in the market.

Some of the key developments in the global insulin pen market include,


• In March 2022, Novo Nordisk A/S launched the smart insulin pen NovoPen 6 and NovoPen Echo Plus in the UK market. By the use of this, people can monitor and record dosing information on their smartphones. These pens can record the amount of insulin injected via a near-field communication mobile application which can be reviewed by patent and healthcare professionals when required.

• In November 2021, Biocon and Viatris launched an interchangeable insulin biosimilar named Semglee which is a substitute for Sanofi’s diabetes drug Lantus. As per the company, the unbranded version of the biosimilar is 65% economical as compared to Sanofi’s Lantus.

Global Insulin Pen Market Analysis and Forecast 2019-2028

Table of Contents

1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. Insulin Pen Manufacturers
6.3.2. Key End-Users
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Rules & Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Insulin Pen Market: Key Investment Analysis
9.1. By Leading Insulin Pen Manufacturers
9.2. By Region
9.3. M&A Activities
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key end-use sector
10. Pricing Analysis
10.1. By Type
10.1.1. Conventional Insulin Pen
10.1.2. Smart Insulin Pen
10.2. By Region
10.2.1. North America
10.2.2. Latin America
10.2.3. Western Europe
10.2.4. Eastern Europe
10.2.5. Asia Pacific
10.2.6. Middle East & Africa
11. Parent Market Overview: Global Medical Devices Market
12. Segmental Analysis
12.1. Global Insulin Pen Market by Type
12.1.1. Segment Overview
12.1.1.1. Conventional Insulin Pen
12.1.1.2. Smart Insulin Pen
12.2. Global Insulin Pen Market by Product Type
12.2.1. Segment Overview
12.2.1.1. Reusable Pen
12.2.1.2. Disposable Pen
12.3. Global Insulin Pen Market by Diabetes Type
12.3.1. Segment Overview
12.3.1.1. Diabetes Type 1
12.3.1.2. Diabetes Type 2
12.4. Global Insulin Pen Market by Distribution Channel
12.4.1. Segment Overview
12.4.1.1. Hospital Pharmacies
12.4.1.2. Conventional Retail Pharmacies
12.4.1.3. Online Pharmacies
12.5. Global Insulin Pen Market by End User
12.5.1. Segment Overview
12.5.1.1. Hospitals
12.5.1.2. Clinics
12.5.1.3. Homecare Settings
12.6. Global Insulin Pen Market by Region
12.6.1. North America
12.6.2. Latin America
12.6.3. Western Europe
12.6.4. Eastern Europe
12.6.5. Asia Pacific
12.6.6. Middle East & Africa
13. Regional Analysis
13.1. North America Insulin Pen Market Analysis and Forecast 2019-2028
13.1.1. Regional Market Overview and Key Takeaways
13.1.2. North America Insulin Pen Market by Type
13.1.3. North America Insulin Pen Market by Product Type
13.1.4. North America Insulin Pen Market by Diabetes Type
13.1.5. North America Insulin Pen Market by Distribution Channel
13.1.6. North America Insulin Pen Market by End User
13.1.7. North America Insulin Pen Market by Country
13.1.7.1. US
13.1.7.2. Canada
13.2. Latin America Insulin Pen Market Analysis and Forecast 2019-2028
13.2.1. Regional Market Overview and Key Takeaways
13.2.2. Latin America Insulin Pen Market by Type
13.2.3. Latin America Insulin Pen Market by Product Type
13.2.4. Latin America Insulin Pen Market by Diabetes Type
13.2.5. Latin America Insulin Pen Market by Distribution Channel
13.2.6. Latin America Insulin Pen Market by End User
13.2.7. Latin America Insulin Pen Market by Country
13.2.7.1. Brazil
13.2.7.2. Mexico
13.2.7.3. Rest of Latin America
13.3. Western Europe Insulin Pen Market Analysis and Forecast 2019-2028
13.3.1. Regional Market Overview and Key Takeaways
13.3.2. Western Europe Insulin Pen Market by Type
13.3.3. Western Europe Insulin Pen Market by Product Type
13.3.4. Western Europe Insulin Pen Market by Diabetes Type
13.3.5. Western Europe Insulin Pen Market by Distribution Channel
13.3.6. Western Europe Insulin Pen Market by End User
13.3.7. Western Europe Insulin Pen Market by Country
13.3.7.1. Germany
13.3.7.2. UK
13.3.7.3. France
13.3.7.4. Spain
13.3.7.5. Italy
13.3.7.6. Benelux
13.3.7.7. Nordic
13.3.7.8. Rest of Western Europe
13.4. Eastern Europe Insulin Pen Market Analysis and Forecast 2019-2028
13.4.1. Regional Market Overview and Key Takeaways
13.4.2. Eastern Europe Insulin Pen Market by Type
13.4.3. Eastern Europe Insulin Pen Market by Product Type
13.4.4. Eastern Europe Insulin Pen Market by Diabetes Type
13.4.5. Eastern Europe Insulin Pen Market by Distribution Channel
13.4.6. Eastern Europe Insulin Pen Market by End User
13.4.7. Eastern Europe Insulin Pen Market by Country
13.4.7.1. Russia
13.4.7.2. Poland
13.4.7.3. Rest of Eastern Europe
13.5. Asia Pacific Insulin Pen Market Analysis and Forecast 2019-2028
13.5.1. Regional Market Overview and Key Takeaways
13.5.2. Asia Pacific Insulin Pen Market by Type
13.5.3. Asia Pacific Insulin Pen Market by Product Type
13.5.4. Asia Pacific Insulin Pen Market by Diabetes Type
13.5.5. Asia Pacific Insulin Pen Market by Distribution Channel
13.5.6. Asia Pacific Insulin Pen Market by End User
13.5.7. Asia Pacific Insulin Pen Market by Country
13.5.7.1. China
13.5.7.2. Japan
13.5.7.3. India
13.5.7.4. South Korea
13.5.7.5. Australia
13.5.7.6. ASEAN
13.5.7.7. Rest of Asia-Pacific
13.6. Middle East & Africa Insulin Pen Market Analysis and Forecast 2019-2028
13.6.1. Regional Market Overview and Key Takeaways
13.6.2. Middle East & Africa Insulin Pen Market by Type
13.6.3. Middle East & Africa Insulin Pen Market by Product Type
13.6.4. Middle East & Africa Insulin Pen Market by Diabetes Type
13.6.5. Middle East & Africa Insulin Pen Market by Distribution Channel
13.6.6. Middle East & Africa Insulin Pen Market by End User
13.6.7. Middle East & Africa Insulin Pen Market by Country
13.6.7.1. GCC
13.6.7.2. South Africa
13.6.7.3. Turkey
13.6.7.4. Rest of the Middle East & Africa
14. Competitive Landscape
14.1. Competition Dashboard
14.1.1. Global and Regional Market Share Analysis
14.1.2. Market Structure
14.2. Competitive Benchmarking
14.3. Key Strategy Analysis
14.4. Company Profiles
14.4.1. Novo Nordisk
14.4.1.1. Company Overview
14.4.1.2. Product/Service Offerings
14.4.1.3. Key Financials
14.4.1.4. Recent Developments
14.4.2. Sanofi SA
14.4.2.1. Company Overview
14.4.2.2. Product/Service Offerings
14.4.2.3. Key Financials
14.4.2.4. Recent Developments
14.4.3. Eli Lilly and Company
14.4.3.1. Company Overview
14.4.3.2. Product/Service Offerings
14.4.3.3. Key Financials
14.4.3.4. Recent Developments
14.4.4. Biocon Limited
14.4.4.1. Company Overview
14.4.4.2. Product/Service Offerings
14.4.4.3. Financials
14.4.4.4. Recent Developments
14.4.5. B. Braun Holding GmbH & Co. KG
14.4.5.1. Company Overview
14.4.5.2. Product/Service Offerings
14.4.5.3. Financials
14.4.5.4. Recent Developments
14.4.6. Owen Mumford Ltd.
14.4.6.1. Company Overview
14.4.6.2. Product/Service Offerings
14.4.6.3. Financials
14.4.6.4. Recent Developments
14.4.7. YpsoMed AG
14.4.7.1. Company Overview
14.4.7.2. Product/Service Offerings
14.4.7.3. Financials
14.4.7.4. Recent Developments
14.4.8. Terumo Medical Corporation
14.4.8.1. Company Overview
14.4.8.2. Product/Service Offerings
14.4.8.3. Financials
14.4.8.4. Recent Developments
14.4.9. Diamesco Co., Ltd.
14.4.9.1. Company Overview
14.4.9.2. Product/Service Offerings
14.4.9.3. Financials
14.4.9.4. Recent Developments
14.4.10. BigFoot Biomedical, Inc.
14.4.10.1. Company Overview
14.4.10.2. Product/Service Offerings
14.4.10.3. Financials
14.4.10.4. Recent Developments
*List not exhaustive (Players can be added or replaced as per the customization).
15. Disclaimer


List of Figures

Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.

In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.

This research methodology has been segmented into following types:

Primary Research:

It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.

Secondary Research:

The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.

Qualitative Research:

It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.

Quantitative Research:

It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.

Tab Four
Our Happy

Clients